Results 121 to 130 of about 4,326,321 (342)

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

BREEAM for Healthcare - a report for NHS Estates and Facilities Policy [PDF]

open access: yes, 2012
This report considers sustainable healthcare properties and in particular the use of BREEAM for Healthcare 2008 and the options for improving sustainability across the ...
Capper, Graham   +2 more
core  

Continuous Monitoring of Bladder Dysfunction in People With Multiple Sclerosis: Wearables for the Bladder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Bladder dysfunction affects over 85% of people with multiple sclerosis (PwMS), yet current assessment methods are limited to periodic in‐clinic evaluations or subjective patient reports, failing to capture real‐world symptom fluctuations.
Valerie J. Block   +8 more
wiley   +1 more source

The Effects of Health Reform on Small Businesses and Their Workers [PDF]

open access: yes, 2011
Synthesizes research findings about how the 2010 healthcare reform will affect small business owners and employees, including savings in healthcare costs and premium contributions, coverage for workers and dependents, offer rates, and number of ...
Linda J. Blumberg   +2 more
core  

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical ...
Andrea Nova   +5 more
wiley   +1 more source

Eliminating Mental and Physical Health Disparities Through Culturally and Linguistically Centered Integrated Healthcare [PDF]

open access: yes, 2017
Since the U.S. Surgeon General’s report on mental health (1999) declared mind and body to be inseparable, integrated healthcare, bringing the body and mind back together, has been gaining significant momentum across the nation as a preferred approach to ...
Martinez, Octavio N., Jr.
core   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji   +9 more
wiley   +1 more source

An Analysis of Current Healthcare Proposals: Obama and McCain [PDF]

open access: yes, 2008
The healthcare system of the U.S. is broken. The next opportunity for overwhelming healthcare system reform will be when the next president takes office.
Terrell, Dan
core   +1 more source

Editorial: Frugal Innovation (April 2018)

open access: yesTechnology Innovation Management Review, 2018
Chris McPhee   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy